位置:首页 > 蛋白库 > ASAP2_MOUSE
ASAP2_MOUSE
ID   ASAP2_MOUSE             Reviewed;         958 AA.
AC   Q7SIG6; Q501K1; Q66JN2;
DT   29-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 3.
DT   03-AUG-2022, entry version 168.
DE   RecName: Full=Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2;
DE   AltName: Full=Development and differentiation-enhancing factor 2;
DE   AltName: Full=Paxillin-associated protein with ARF GAP activity 3;
DE            Short=PAG3;
DE   AltName: Full=Pyk2 C-terminus-associated protein;
DE            Short=PAP;
GN   Name=Asap2; Synonyms=Ddef2, Gm1523, Gm592;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 425-432, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Hippocampus;
RA   Lubec G., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [3]
RP   FUNCTION, PHOSPHORYLATION, INTERACTION WITH PTK2B AND SRC, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10022920; DOI=10.1128/mcb.19.3.2338;
RA   Andreev J., Simon J.-P., Sabatini D.D., Kam J., Plowman G., Randazzo P.A.,
RA   Schlessinger J.;
RT   "Identification of a new Pyk2 target protein with Arf-GAP activity.";
RL   Mol. Cell. Biol. 19:2338-2350(1999).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH ARF6 AND ACTIN
RP   FILAMENTS.
RX   PubMed=11304556; DOI=10.1084/jem.193.8.955;
RA   Uchida H., Kondo A., Yoshimura Y., Mazaki Y., Sabe H.;
RT   "PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation
RT   factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of
RT   macrophages.";
RL   J. Exp. Med. 193:955-966(2001).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion affinity
RT   chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Kidney, Liver, Lung, Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 421-679 IN COMPLEX WITH A ZINC
RP   ION, AND MUTAGENESIS OF TRP-449; ILE-460; ARG-467; LEU-481 AND ASP-482.
RX   PubMed=10601011; DOI=10.1093/emboj/18.24.6890;
RA   Mandiyan V., Andreev J., Schlessinger J., Hubbard S.R.;
RT   "Crystal structure of the ARF-GAP domain and ankyrin repeats of PYK2-
RT   associated protein beta.";
RL   EMBO J. 18:6890-6898(1999).
CC   -!- FUNCTION: Activates the small GTPases ARF1, ARF5 and ARF6. Regulates
CC       the formation of post-Golgi vesicles and modulates constitutive
CC       secretion. Modulates phagocytosis mediated by Fc gamma receptor and
CC       ARF6. Modulates PXN recruitment to focal contacts and cell migration
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:10022920,
CC       ECO:0000269|PubMed:11304556}.
CC   -!- SUBUNIT: Binds PXN, ARF1, ARF5, ARF6, PTK2B and SRC.
CC       {ECO:0000269|PubMed:10601011}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus, Golgi stack membrane;
CC       Peripheral membrane protein. Cell membrane; Peripheral membrane
CC       protein. Note=Colocalizes with F-actin and ARF6 in phagocytic cups.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7SIG6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7SIG6-2; Sequence=VSP_014776, VSP_014777;
CC   -!- DOMAIN: The conserved Arg-467 in the Arf-GAP domain probably becomes
CC       part of the active site of bound small GTPases and is necessary for GTP
CC       hydrolysis.
CC   -!- PTM: Phosphorylated on tyrosine residues by SRC and PTK2B.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC096022; AAH96022.1; -; mRNA.
DR   EMBL; BC080847; AAH80847.1; -; mRNA.
DR   CCDS; CCDS56832.1; -. [Q7SIG6-1]
DR   RefSeq; NP_001004364.2; NM_001004364.2.
DR   RefSeq; NP_001091637.1; NM_001098168.1. [Q7SIG6-1]
DR   RefSeq; NP_001128664.1; NM_001135192.1.
DR   PDB; 1DCQ; X-ray; 2.10 A; A=421-697.
DR   PDBsum; 1DCQ; -.
DR   AlphaFoldDB; Q7SIG6; -.
DR   SMR; Q7SIG6; -.
DR   BioGRID; 229271; 15.
DR   IntAct; Q7SIG6; 2.
DR   MINT; Q7SIG6; -.
DR   STRING; 10090.ENSMUSP00000063217; -.
DR   iPTMnet; Q7SIG6; -.
DR   PhosphoSitePlus; Q7SIG6; -.
DR   jPOST; Q7SIG6; -.
DR   MaxQB; Q7SIG6; -.
DR   PeptideAtlas; Q7SIG6; -.
DR   PRIDE; Q7SIG6; -.
DR   ProteomicsDB; 283178; -. [Q7SIG6-1]
DR   ProteomicsDB; 283179; -. [Q7SIG6-2]
DR   Antibodypedia; 4352; 108 antibodies from 28 providers.
DR   DNASU; 211914; -.
DR   Ensembl; ENSMUST00000090834; ENSMUSP00000088344; ENSMUSG00000052632. [Q7SIG6-2]
DR   Ensembl; ENSMUST00000101562; ENSMUSP00000099098; ENSMUSG00000052632. [Q7SIG6-1]
DR   GeneID; 211914; -.
DR   KEGG; mmu:211914; -.
DR   UCSC; uc007ndi.1; mouse. [Q7SIG6-1]
DR   UCSC; uc011ykr.1; mouse. [Q7SIG6-2]
DR   CTD; 8853; -.
DR   MGI; MGI:2685438; Asap2.
DR   VEuPathDB; HostDB:ENSMUSG00000052632; -.
DR   eggNOG; KOG0521; Eukaryota.
DR   GeneTree; ENSGT00940000155623; -.
DR   InParanoid; Q7SIG6; -.
DR   OrthoDB; 751525at2759; -.
DR   BioGRID-ORCS; 211914; 1 hit in 73 CRISPR screens.
DR   ChiTaRS; Asap2; mouse.
DR   EvolutionaryTrace; Q7SIG6; -.
DR   PRO; PR:Q7SIG6; -.
DR   Proteomes; UP000000589; Chromosome 12.
DR   RNAct; Q7SIG6; protein.
DR   Bgee; ENSMUSG00000052632; Expressed in lumbar subsegment of spinal cord and 190 other tissues.
DR   ExpressionAtlas; Q7SIG6; baseline and differential.
DR   Genevisible; Q7SIG6; MM.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005096; F:GTPase activator activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:InterPro.
DR   CDD; cd13251; PH_ASAP; 1.
DR   CDD; cd11966; SH3_ASAP2; 1.
DR   Gene3D; 1.10.220.150; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR037278; ARFGAP/RecO.
DR   InterPro; IPR001164; ArfGAP_dom.
DR   InterPro; IPR038508; ArfGAP_dom_sf.
DR   InterPro; IPR043593; ASAP.
DR   InterPro; IPR035677; ASAP2_SH3.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR037844; PH_ASAP.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR45854; PTHR45854; 2.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF01412; ArfGap; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00405; REVINTRACTNG.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM00105; ArfGap; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF57863; SSF57863; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS50115; ARFGAP; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; Cell membrane; Coiled coil;
KW   Cytoplasm; Direct protein sequencing; Golgi apparatus; GTPase activation;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Repeat;
KW   SH3 domain; Zinc.
FT   CHAIN           1..958
FT                   /note="Arf-GAP with SH3 domain, ANK repeat and PH domain-
FT                   containing protein 2"
FT                   /id="PRO_0000074199"
FT   DOMAIN          308..400
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          424..546
FT                   /note="Arf-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00288"
FT   REPEAT          587..619
FT                   /note="ANK 1"
FT   REPEAT          623..655
FT                   /note="ANK 2"
FT   DOMAIN          896..958
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          283..316
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          703..724
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          767..900
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          259..286
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        781..806
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        807..830
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        831..846
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         704
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         861
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43150"
FT   VAR_SEQ         284..286
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014776"
FT   VAR_SEQ         345..490
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014777"
FT   MUTAGEN         449
FT                   /note="W->A: Strongly reduces Arf-GAP mediated stimulation
FT                   of GTP hydrolysis."
FT                   /evidence="ECO:0000269|PubMed:10601011"
FT   MUTAGEN         460
FT                   /note="I->A: Reduces Arf-GAP mediated stimulation of GTP
FT                   hydrolysis 100-fold and abolishes Arf-GAP mediated
FT                   stimulation of GTP hydrolysis; when associated with A-306."
FT                   /evidence="ECO:0000269|PubMed:10601011"
FT   MUTAGEN         467
FT                   /note="R->A: Abolishes Arf-GAP mediated stimulation of GTP
FT                   hydrolysis."
FT                   /evidence="ECO:0000269|PubMed:10601011"
FT   MUTAGEN         467
FT                   /note="R->K: Reduces Arf-GAP mediated stimulation of GTP
FT                   hydrolysis more than 10000-fold."
FT                   /evidence="ECO:0000269|PubMed:10601011"
FT   MUTAGEN         481
FT                   /note="L->A: Reduces Arf-GAP mediated stimulation of GTP
FT                   hydrolysis 100-fold and abolishes Arf-GAP mediated
FT                   stimulation of GTP hydrolysis; when associated with A-285."
FT                   /evidence="ECO:0000269|PubMed:10601011"
FT   MUTAGEN         482
FT                   /note="D->A: Reduces Arf-GAP mediated stimulation of GTP
FT                   hydrolysis 1000-fold."
FT                   /evidence="ECO:0000269|PubMed:10601011"
FT   HELIX           423..432
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            434..437
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            440..442
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   STRAND          449..451
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            452..454
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           460..469
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            471..473
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   STRAND          476..478
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            479..481
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           486..489
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           490..494
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           497..504
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            505..507
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   STRAND          510..512
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           522..533
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   STRAND          543..545
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           546..558
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           562..570
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           591..598
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   TURN            601..603
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           604..613
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           627..633
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           637..645
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           660..666
FT                   /evidence="ECO:0007829|PDB:1DCQ"
FT   HELIX           670..680
FT                   /evidence="ECO:0007829|PDB:1DCQ"
SQ   SEQUENCE   958 AA;  106805 MW;  2CA0056C2AD14D7E CRC64;
     MPDQISVSEF VAETHEDYKA PTASSFTTRT AQCRNTVAAI EEALDVDRMV LYKMKKSVKA
     INISGLAHVE NEEQYTQALE KFGGNCVCRD DPDLGSAFLK FSVFTKELTA LFKNLIQNMN
     NIISFPLDSL LKGDLKGVKG DLKKPFDKAW KDYETKITKI EKEKKEHAKL HGMIRTEISG
     AEIAEEMEKE RRFFQLQMCE YLLKVNEIKV KKGVDLLQNL IKYFHAQCNF FQDGLKAVES
     LKPSIETLST DLHTIKQAQD EERRQLIQLR DILKSALQVE QKESRRDSQL RQSTAYSLHQ
     PQGNKEHGTE RNGNLYKKSD GIRKVWQKRK CSVKNGFLTI SHGTANRPPA KLNLLTCQVK
     TNPEEKKCFD LISHDRTYHF QAEDEQECQI WMSVLQNSKE EALNNAFKGD DNTGENNIVQ
     ELTKEIISEV QRMTGNDVCC DCGAPDPTWL STNLGILTCI ECSGIHRELG VHYSRMQSLT
     LDVLGTSELL LAKNIGNAGF NEIMECCLPS EDPVKPNPGS DMIARKDYIT AKYMERRYAR
     KKHADTAAKL HSLCEAVKTR DIFGLLQAYA DGVDLTEKIP LANGHEPDET ALHLAVRSVD
     RTSLHIVDFL VQNSGNLDKQ TGKGSTALHY CCLTDNAECL KLLLRGKASI EIANESGETP
     LDIAKRLKHE HCEELLTQAL SGRFNSHVHV EYEWRLLHED LDESDDDVDE KLQPSPNRRE
     DRPVSFYQLG SSQFQSNAVS LARDTANLTK DKQRGFGPSI LQNETYGAIL SGSPPSSQSI
     PPSTTSAPPL PPRNVGKDPL TTTPPPPVAK TSGTLEAMNQ PSKSSQPGTS QSKPPPLPPQ
     PPSRLPQKKP ASGTDKPTPL TNKGQPRGPE ASGPLSNAMA LQPPAPMPRK SQATKSKPKR
     VKALYNCVAD NPDELTFSEG DVIIVDGEED QEWWIGHIDG EPSRKGAFPV SFVHFIAD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024